Sponsored Links
| Generic Drug Makers Back Away From Health Reform Tab |
 |
 |
 |
| Pharmacy - Pharma Industry - Biotech Industry | |||
|
Kaiser Health News staff writer Phil Galewitz reports on the position generic drug makers have taken regarding how the costs of health reform should be paid. "Generic drug makers - which have saved Americans hundreds of billions of dollars in the past decade with their low-cost, copycat medicines - don't think they should join other health industries to finance a health care overhaul" (10/15). Read more: Pharma Industry / Biotech Industry News From Medical News Today
|